Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3PXT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,248
Award facts
- Contract value 100% obligated
- $14,248.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $14,248.09 delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 26, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies globally in support of military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies an extensive portfolio of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent delivery of brand-name and generic pharmaceuticals across multiple therapeutic domains, including neurological treatments such as Vraylar, supporting military and veteran healthcare procurement needs. The DLA, as the funding agency, leverages this established vendor relationship to fulfill pharmaceutical supply requirements across its medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F3PXT?
SPE2DR26F3PXT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F3PXT worth?
The government has obligated $14,248 on SPE2DR26F3PXT.
Is contract SPE2DR26F3PXT an order under another contract?
Yes. SPE2DR26F3PXT is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3PXT competed?
The extent of competition for SPE2DR26F3PXT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award